These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9492990)

  • 1. Regulation of self-tolerance by CD80/CD86 interactions.
    Lu P; Wang YL; Linsley PS
    Curr Opin Immunol; 1997 Dec; 9(6):858-62. PubMed ID: 9492990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
    Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
    J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's the difference between CD80 and CD86?
    Sansom DM; Manzotti CN; Zheng Y
    Trends Immunol; 2003 Jun; 24(6):314-9. PubMed ID: 12810107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity.
    Nuriya S; Yagita H; Okumura K; Azuma M
    Int Immunol; 1996 Jun; 8(6):917-26. PubMed ID: 8671681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance.
    Silver PB; Hathcock KS; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(9):5041-7. PubMed ID: 11046033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
    Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
    Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 9. Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation.
    Mark DA; Donovan CE; De Sanctis GT; Krinzman SJ; Kobzik L; Linsley PS; Sayegh MH; Lederer J; Perkins DL; Finn PW
    Int Immunol; 1998 Nov; 10(11):1647-55. PubMed ID: 9846693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
    Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
    J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
    Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
    Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased dependency of CD80 versus CD86 in the induction of transcription factors regulating the human IL-2 promoter.
    Olsson C; Michaëlsson E; Parra E; Pettersson U; Lando PA; Dohlsten M
    Int Immunol; 1998 Apr; 10(4):499-506. PubMed ID: 9620606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-mediated costimulation and the immune response.
    Schultze J; Nadler LM; Gribben JG
    Blood Rev; 1996 Jun; 10(2):111-27. PubMed ID: 8813343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
    Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.
    Pettit SJ; Ali S; O'Flaherty E; Griffiths TR; Neal DE; Kirby JA
    Clin Exp Immunol; 1999 Apr; 116(1):48-56. PubMed ID: 10209504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice.
    Kano M; Bashuda H; Yagita H; Okumura K; Morishita Y
    Transplantation; 1998 Mar; 65(6):837-43. PubMed ID: 9539097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of rat CD80 and CD86 by molecular cloning and mAb.
    Maeda K; Sato T; Azuma M; Yagita H; Okumura K
    Int Immunol; 1997 Jul; 9(7):993-1000. PubMed ID: 9237108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple negative feedbacks on CD152 expression in allograft tolerance.
    Tsai MK; Ho HN; Chien HF; Tzeng MC; Chen CH; Lee PH
    Transplantation; 2005 Jan; 79(2):174-81. PubMed ID: 15665765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.